Literature DB >> 1315358

IFN-gamma mediates increased glucocorticoid receptor expression in murine macrophages.

C A Salkowski1, S N Vogel.   

Abstract

Exposure of the murine macrophage cell line, RAW 264.7, to murine rIFN-gamma resulted in a significant increase in the number of glucocorticoid receptors (GcR). A doubling in the number of GcR was observed as early as 24 h after rIFN-gamma treatment, and receptor number was maximal by 36 h after rIFN-gamma treatment and represented approximately a fourfold increase. Scatchard analysis indicated that a twofold increase in GcR affinity was concomitant with the rIFN-gamma-induced increase in GcR number in RAW 264.7 cells. Increased GcR numbers were induced after exposure of RAW 264.7 cells to as little as 0.1 U/ml rIFN-gamma, and optimal expression was observed at 5 U/ml. Treatment of peritoneal exudate macrophages from C3H/OuJ mice and the LPS hyporesponsive mouse strain, C3H/HeJ, with rIFN-gamma induced an approximately twofold increase in the GcR with no concomitant change in receptor affinity. These results suggest that IFN-gamma may be essential not only for macrophage activation, but also for increasing macrophage sensitivity to feedback inhibition by glucocorticoids by increasing the number and/or affinity of available GcR.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315358

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Gamma interferon down-regulates glucocorticoid receptor expression and attenuates hormone action in a human osteosarcoma cell line.

Authors:  L N Song
Journal:  Endocrine       Date:  1995-10       Impact factor: 3.633

2.  Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice.

Authors:  F Alves-Rosa; M Vulcano; M Beigier-Bompadre; G Fernández; M Palermo; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

3.  Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones.

Authors:  L Lanza; L Peirano; O Bosco; P Contini; G Filaci; M Setti; F Puppo; F Indiveri; M Scudeletti
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

4.  Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: differential responses of Mycobacterium bovis BCG-resistant and -susceptible mice.

Authors:  D H Brown; J Sheridan; D Pearl; B S Zwilling
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A.

Authors:  B E Henricson; C L Manthey; P Y Perera; T A Hamilton; S N Vogel
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

6.  Modulation of interferon-gamma-induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-beta 1, interleukin-4, noradrenaline and glucocorticoids.

Authors:  A J Loughlin; M N Woodroofe; M L Cuzner
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

Review 7.  The glucocorticoid receptor: a revisited target for toxins.

Authors:  Jeanette I Webster Marketon; Esther M Sternberg
Journal:  Toxins (Basel)       Date:  2010-06-09       Impact factor: 4.546

8.  Modulation of immune responses in stress by Yoga.

Authors:  Sarika Arora; Jayashree Bhattacharjee
Journal:  Int J Yoga       Date:  2008-07

Review 9.  Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.

Authors:  V H van der Velden
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

10.  Glucocorticoid receptor expression in human bronchial epithelial cells: effects of smoking and COPD.

Authors:  M M Verheggen; P W Adriaansen-Soeting; C A Berrevoets; P T van Hal; A O Brinkmann; H C Hoogsteden; M A Versnel
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.